패혈증 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Sepsis Treatment Market size is expected to reach USD 13.13 Billion in 2034 from USD 7.22 Billion (2025) growing at a CAGR of 6.87% during 2026-2034.

The global sepsis treatment market is growing steadily due to the increasing incidence of severe infections and the rising awareness of sepsis as a life-threatening medical condition. Sepsis occurs when the body's response to infection causes widespread inflammation and organ dysfunction. Early diagnosis and effective treatment are critical to improving survival rates, which is driving the demand for advanced therapeutic solutions.

Key drivers of the market include the growing number of hospital admissions for severe infections and increasing awareness among healthcare professionals about early sepsis detection. Advances in diagnostic technologies and improvements in intensive care unit infrastructure are also supporting market growth. In addition, government initiatives promoting better infection management and patient safety are encouraging the adoption of effective sepsis treatment protocols.

Looking ahead, the sepsis treatment market is expected to expand due to ongoing research into novel therapeutic approaches and improved diagnostic tools. Pharmaceutical companies are focusing on developing targeted therapies and immunomodulatory treatments to improve patient outcomes. As healthcare systems continue to emphasize early intervention and critical care management, demand for effective sepsis treatments is likely to grow.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Severe Sepsis
• Sepsis Shock
• Sepsis in Need of Blood Purification

By Therapy

• Continuous Renal Replacement Therapies (CRRT)
• Intermittent Hemodialysis
• Sustained Low-efficiency Daily Dialysis (SLED)
• Others

By End User

• Hospitals
• Specialty Centers
• Others

COMPANIES PROFILED

• Baxter International, Inc, Fresenius Medical Care AG Co KGaA, Nipro Corporation, Asahi Kasei, B Braun Group, CytoSorbents Corporation, Medtronic ple, Nikkiso Co, Ltd, Medica SPA, Toray Industries, Merck Co, Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SEPSIS TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Severe Sepsis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Sepsis Shock Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Sepsis in Need of Blood Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SEPSIS TREATMENT MARKET: BY THERAPY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapy
• 5.2. Continuous Renal Replacement Therapies (CRRT) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Intermittent Hemodialysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Sustained Low-efficiency Daily Dialysis (SLED) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SEPSIS TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SEPSIS TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Therapy
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Therapy
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Therapy
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Therapy
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Therapy
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SEPSIS TREATMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Baxter InternationalInc
  • 9.2.2 Fresenius Medical Care AG & Co. KGaA
  • 9.2.3 Nipro Corporation
  • 9.2.4 Asahi Kasei
  • 9.2.5 B. Braun Group
  • 9.2.6 CytoSorbents Corporation
  • 9.2.7 Medtronic Ple
  • 9.2.8 Nikkiso CoLtd
  • 9.2.9 Medica SPA
  • 9.2.10 Toray Industries
  • 9.2.11 Merck & Co.Inc